Status:
ACTIVE_NOT_RECRUITING
Effects of Blueberry on Gut Microbiota and Metabolic Syndrome
Lead Sponsor:
Laval University
Conditions:
Gut Microbiota
Metabolic Syndrome
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
There is growing evidence that nutritional intervention with dietary polyphenols can positively modulate the gut microbiota to improve cardiometabolic health. Whether the beneficial effects of blueber...
Eligibility Criteria
Inclusion
- Men and premenopause women in good health
- Caucasians
- At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
- At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L
Exclusion
- Metabolic disorders (hypertension, diabetes, hypercholesterolemia)
- Regular use of medication affecting study parameters
- Use of natural health product in the last 3 months
- Use of antibiotics in the last 3 months
- Nicotine users
- Allergy or intolerance for blueberries
- Blueberry taste aversion
- More than 2 alcohol drinks par day
- Particular dietary habits (vegetarism, gluten-free diet, cetogenic diet...)
- Weight change of more than 5% in the last 3 months
- Surgery in the last 3 months or planed during the study
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT03266055
Start Date
September 1 2017
End Date
December 1 2025
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University
Québec, Canada, G1V0A6